⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR
Rinck Advertising and Novonesis Earn Silver ADDY Award for Illustration from AAF Baltimore
globenewswire.com
NVS
Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More
globenewswire.com
MRK
EXEL
PFE
BMY
AZN
NVS
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
globenewswire.com
PFE
NVS
EXEL
BMY
AMRX
JNJ
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health
globenewswire.com
NVO
NVS
DVA
Chemotherapy Market to Hit $20.99 Billion by 2035, Driven by Rising Cancer Incidence – SNS Insider
globenewswire.com
NVS
PFE
Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth
globenewswire.com
TMO
MRK
PFE
NVS
Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry
globenewswire.com
MRK
SNY
BMY
NVS
CHKP
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
globenewswire.com
PFE
MRK
SNY
BMY
AZN
NVS
GSK
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY